Epidemiology

  • Age of onset: adults > 60 years

Etiology

  • The primary (idiopathic) form is most common, with age as a major risk factor.
  • Secondary forms
    • Joint trauma/damage: including joint surgery, previous juvenile idiopathic arthritis, and Osteoarthritis
    • Metabolic disorders: including hyperparathyroidism, hemochromatosis, hypomagnesemia, hypophosphatasia, and possibly gout
    • Familial chondrocalcinosis: due to mutations in the CCAL1 or CCAL2 genes

Pathophysiology

Deposition of calcium pyrophosphate dihydrate (CPP or CPPD) crystals in articular cartilage → paroxysmal joint inflammation and cartilage destruction → inflammatory arthritis (crystalline arthritis)


Clinical features

Acute CPP crystal arthritis (pseudogout)

  • Clinical features
    • Acute attack of pain and swelling in the affected joint(s)
    • Monoarthritis (occasionally oligoarthritis)
    • Most commonly affects the knee and wrist; can also affect other large joints (e.g., hips, ankles)
    • Typically self-limited
  • Features that differ from acute gout
    • Longer duration of acute attacks
      • Up to several months
    • Possible systemic symptoms
      • E.g., fever, chills, altered mental status in the elderly

Chronic CPP crystal arthritis

  • Osteoarthritis-like presentation (osteoarthritis with CPPD; pseudo-osteoarthritis)
    • Most common form of CPPD disease
    • Characterized by progressive joint degeneration
      • Usually polyarticular; can occur in joints not typically affected by OA
      • More severe than typical OA
      • Often associated with pseudogout-like flares of acute inflammatory arthritis

Diagnostics

Arthrocentesis and synovial fluid analysis (SFA)

  • Cloudy fluid
  • Polarized light microscopy (with a red filter) appearance of CPP crystals
    • Rhomboid-shaped crystals that are weakly positively birefringent
    • Crystals appear blue when their optical axis is oriented parallel to the polarizer.
    • Crystals appear yellow when their axis is perpendicular to the polarizer.
  • Cell count: WBC > 2000/μL with > 50% neutrophils

Imaging

  • X-ray of the affected joint(s)
    • Chondrocalcinosis: calcification of cartilage in the affected joints

Treatment